一种FtsZ抑制剂,可以利用Siderophore-Ferric铁吸收输送系统对抗阴性细菌病原体的活性
Eric J Bryan1, Qi Qiao2, Yuxuan Wang1
1Department of Pharmacology, Rutgers Robert Wood Johnson Medical School, Piscataway, NJ 08854, USA.
Antibiotics (Basel, Switzerland)
|March 27, 2024
概括
一种新型的FtsZ抑制剂,RUP4,通过使用铁吸收通路来向阴性细菌. 这种新的抗生素策略显示出对抗多药耐药性病原体的前景,如Klebsiella pneumoniae和Acinetobacter baumannii.
科学领域:
- 微生物学 微生物学
- 药物发现 药物发现 药物发现
- 细菌病原体的产生
背景情况:
- 耐多药格拉姆阴性细菌构成了全球健康的重大威胁.
- FtsZ是细菌细胞分裂的关键蛋白质,也是有前途的抗生素标.
- 现有的FtsZ抑制剂与格拉姆阴性病原体的细胞内积累作斗争.
研究的目的:
- 设计和评估一种新型的FtsZ抑制剂,可增强格兰氏阴性细菌的吸收.
- 调查新抑制剂的作用机制和协同作用潜力.
主要方法:
- RUP4的设计,是一种FtsZ抑制剂,含有甲醇 siderophore用于铁和吸收.
- 测试RUP4对Klebsiella肺炎和Acinetobacter baumannii的活性.
- 在K. pneumoniae.中对RUP4吸收途径的遗传分析.
- 评估RUP4与其他抗生素的协同作用.
主要成果:
- RUP4对K. pneumoniae和A. baumannii表现出活性,这取决于Fe3+化.
- 限制铁的条件提高了RUP4的疗效.
- RUP4使用FepA,CirA和FhuBC载体进入K. pneumoniae.
- RUP4显示了与准PBP2的β-乳酸盐和MreB抑制剂的杀菌协同作用.
结论:
- 将Fe3+化部分纳入FtsZ抑制剂中可以增强对格兰氏阴性病原体的活性.
- RUP4代表了一种有前途的新策略,用于对抗多药性耐药性格拉姆阴性感染.
- 针对细菌的铁吸收途径可以克服抗生素细胞内积累的局限性.
更多相关视频
12:36High-throughput Siderophore Screening from Environmental Samples: Plant Tissues, Bulk Soils, and Rhizosphere Soils
Published on: February 9, 2019
12.6K
15:03Synthesis of Functionalized Magnetic Nanoparticles, Their Conjugation with the Siderophore Feroxamine and its Evaluation for Bacteria Detection
Published on: June 16, 2020
9.3K
相关概念视频
Antimicrobial Proteins
985
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
985
Combined Effects of Drugs: Synergism
3.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.9K
